|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.86/-0.83
|
企業價值
16.60M
|
資產負債 |
每股賬面淨值
0.24
|
現金流量 |
現金流量率
--
|
損益表 |
收益
226.00K
|
每股收益
0.01
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/06/13 07:46 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. |